Relievant's Intraceptâ„¢ technology is based on the groundbreaking research of Micheal Heggeness, MD, PhD of the Baylor College of Medicine. The system utilizes a small probe that is positioned in the vertebrae where it uses radio frequency ablation to target one of the culprit nerves rendering it unable to transmit. The treatment is performed under real-time fluoroscopic guidance and takes approximately one hour to complete.